Atwood & Palmer Inc’s United Therapeutics Corp Del Position
Does Atwood & Palmer Inc own United Therapeutics Corp Del (UTH)? Yes — 61.5K shares worth $33M (+1.78% of its 13F portfolio) as of Q2 2026, down from 62.4K shares the prior filed quarter.
Position Value
$33M
Q2 2026
Shares
61.5K
% of Portfolio
+1.78%
Quarters Held
17
currently held
Position History UTH
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 61.5K | $33M | +1.78% |
| Q1 2026 | 62.4K | $37M | +2.09% |
| Q4 2025 | 63.5K | $31M | +1.76% |
| Q3 2025 | 63.9K | $27M | +1.57% |
| Q2 2025 | 63.9K | $18M | +1.15% |
| Q1 2025 | 63.7K | $20M | +1.36% |
| Q4 2024 | 64.6K | $23M | +1.56% |
| Q3 2024 | 64.1K | $23M | +1.56% |
| Q2 2024 | 63.8K | $20M | +1.54% |
| Q1 2024 | 63.6K | $15M | +1.11% |
| Q4 2023 | 59.9K | $13M | +1.06% |
| Q3 2023 | 59.6K | $13M | +1.18% |
| Q2 2023 | 59.0K | $13M | +1.16% |
| Q1 2023 | 58.6K | $13M | +1.23% |
| Q4 2022 | 56.2K | $16M | +1.41% |
| Q3 2022 | 55.5K | $12M | +1.15% |
| Q2 2022 | 54.8K | $13M | +1.26% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atwood & Palmer Inc’s full portfolio or all institutional holders of UTH.